Cargando…

Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension

AIMS: Upregulation of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) contributes to the pathogenesis of cardiovascular disease, including hypertension. Transgenic rats expressing the human angiotensinogen gene [TGR (hAGT)L1623] are a new novel humanized model of hypertension that associates...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaoqiang, Cao, Jing, Chen, Zhe, Liu, Yixi, VonCannon, Jessica L., Cheng, Heng Jie, Ferrario, Carlos M., Cheng, Che Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344767/
https://www.ncbi.nlm.nih.gov/pubmed/37456012
http://dx.doi.org/10.1016/j.heliyon.2023.e17851
_version_ 1785072932497653760
author Sun, Xiaoqiang
Cao, Jing
Chen, Zhe
Liu, Yixi
VonCannon, Jessica L.
Cheng, Heng Jie
Ferrario, Carlos M.
Cheng, Che Ping
author_facet Sun, Xiaoqiang
Cao, Jing
Chen, Zhe
Liu, Yixi
VonCannon, Jessica L.
Cheng, Heng Jie
Ferrario, Carlos M.
Cheng, Che Ping
author_sort Sun, Xiaoqiang
collection PubMed
description AIMS: Upregulation of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) contributes to the pathogenesis of cardiovascular disease, including hypertension. Transgenic rats expressing the human angiotensinogen gene [TGR (hAGT)L1623] are a new novel humanized model of hypertension that associates with declines in cardiac contractile function and β-adrenergic receptor (AR) reserve. The molecular mechanisms are unclear. We tested the hypothesis that in TGR (hAGT)L1623 rats, left ventricular (LV) myocyte CaMKIIδ and β(3)-AR are upregulated, but β(1)-AR is down-regulated, which are important causes of cardiac dysfunction and β-AR desensitization. MAIN METHODS: We compared LV myocyte CaMKIIδ, CaMKIIδ phosphorylation (at Thr287) (pCaMKIIδ), and β(1)-and β(3)-AR expressions and determined myocyte functional and [Ca(2+)](I) transient ([Ca(2+)](iT)) responses to β-AR stimulation with and without pretreatment of myocytes using an inhibitor of CaMKII, KN-93 (10(−6) M, 30 min) in male Sprague Dawley (SD; N = 10) control and TGR (hAGT)L1623 (N = 10) adult rats. KEY FINDINGS: Hypertension in TGR (hAGT)L1623 rats was accompanied by significantly increased LV myocyte β(3)-AR protein levels and reduced β(1)-AR protein levels. CaMKIIδ phosphorylation (at Thr287), pCaMKIIδ was significantly increased by 35%. These changes were followed by significantly reduced basal cell contraction (dL/dt(max)), relaxation (dR/dt(max)), and [Ca(2+)](iT). Isoproterenol (10(−8) M) produced significantly smaller increases in dL/dt(max), dR/dt(max), and [Ca(2+)](iT). Moreover, only in TGR (hAGT)L1623 rats, pretreatment of LV myocytes with KN-93 (10(−6) M, 30 min) fully restored normal basal and isoproterenol-stimulated myocyte contraction, relaxation, and [Ca(2+)](iT). SIGNIFICANCE: LV myocyte CaMKIIδ overactivation with associated contrast changes in β(3)-AR and β(1)-AR may be the key molecular mechanism for the abnormal contractile phenotype and β-AR desensitization in this humanized model of hypertension.
format Online
Article
Text
id pubmed-10344767
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103447672023-07-15 Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension Sun, Xiaoqiang Cao, Jing Chen, Zhe Liu, Yixi VonCannon, Jessica L. Cheng, Heng Jie Ferrario, Carlos M. Cheng, Che Ping Heliyon Research Article AIMS: Upregulation of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) contributes to the pathogenesis of cardiovascular disease, including hypertension. Transgenic rats expressing the human angiotensinogen gene [TGR (hAGT)L1623] are a new novel humanized model of hypertension that associates with declines in cardiac contractile function and β-adrenergic receptor (AR) reserve. The molecular mechanisms are unclear. We tested the hypothesis that in TGR (hAGT)L1623 rats, left ventricular (LV) myocyte CaMKIIδ and β(3)-AR are upregulated, but β(1)-AR is down-regulated, which are important causes of cardiac dysfunction and β-AR desensitization. MAIN METHODS: We compared LV myocyte CaMKIIδ, CaMKIIδ phosphorylation (at Thr287) (pCaMKIIδ), and β(1)-and β(3)-AR expressions and determined myocyte functional and [Ca(2+)](I) transient ([Ca(2+)](iT)) responses to β-AR stimulation with and without pretreatment of myocytes using an inhibitor of CaMKII, KN-93 (10(−6) M, 30 min) in male Sprague Dawley (SD; N = 10) control and TGR (hAGT)L1623 (N = 10) adult rats. KEY FINDINGS: Hypertension in TGR (hAGT)L1623 rats was accompanied by significantly increased LV myocyte β(3)-AR protein levels and reduced β(1)-AR protein levels. CaMKIIδ phosphorylation (at Thr287), pCaMKIIδ was significantly increased by 35%. These changes were followed by significantly reduced basal cell contraction (dL/dt(max)), relaxation (dR/dt(max)), and [Ca(2+)](iT). Isoproterenol (10(−8) M) produced significantly smaller increases in dL/dt(max), dR/dt(max), and [Ca(2+)](iT). Moreover, only in TGR (hAGT)L1623 rats, pretreatment of LV myocytes with KN-93 (10(−6) M, 30 min) fully restored normal basal and isoproterenol-stimulated myocyte contraction, relaxation, and [Ca(2+)](iT). SIGNIFICANCE: LV myocyte CaMKIIδ overactivation with associated contrast changes in β(3)-AR and β(1)-AR may be the key molecular mechanism for the abnormal contractile phenotype and β-AR desensitization in this humanized model of hypertension. Elsevier 2023-06-30 /pmc/articles/PMC10344767/ /pubmed/37456012 http://dx.doi.org/10.1016/j.heliyon.2023.e17851 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Sun, Xiaoqiang
Cao, Jing
Chen, Zhe
Liu, Yixi
VonCannon, Jessica L.
Cheng, Heng Jie
Ferrario, Carlos M.
Cheng, Che Ping
Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
title Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
title_full Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
title_fullStr Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
title_full_unstemmed Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
title_short Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
title_sort increased camkii activation and contrast changes of cardiac β1-and β3-adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344767/
https://www.ncbi.nlm.nih.gov/pubmed/37456012
http://dx.doi.org/10.1016/j.heliyon.2023.e17851
work_keys_str_mv AT sunxiaoqiang increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension
AT caojing increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension
AT chenzhe increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension
AT liuyixi increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension
AT voncannonjessical increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension
AT chenghengjie increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension
AT ferrariocarlosm increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension
AT chengcheping increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension